TAK-935 Multiple Rising Dose Study in Healthy Participants
NCT02539134
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Interventions
DRUG:
TAK-935
DRUG:
Placebo
Sponsor
Takeda